AU2001252772A1 - Use of amines - Google Patents

Use of amines

Info

Publication number
AU2001252772A1
AU2001252772A1 AU2001252772A AU5277201A AU2001252772A1 AU 2001252772 A1 AU2001252772 A1 AU 2001252772A1 AU 2001252772 A AU2001252772 A AU 2001252772A AU 5277201 A AU5277201 A AU 5277201A AU 2001252772 A1 AU2001252772 A1 AU 2001252772A1
Authority
AU
Australia
Prior art keywords
combatting
amines
activation
preventing
kinin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001252772A
Inventor
Gunn Ragnhild Hoigaard Bjerke
Anne Juelsrud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Publication of AU2001252772A1 publication Critical patent/AU2001252772A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Lubricants (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This application relates to the use of certain amines of formula (I) for combatting and preventing systemic and local complement activation, and in particular to the use of meglumine and derivatives and optionally salts thereof in combatting and preventing said activation. The amines are also of use in combatting activation of the kinin/kallikrein system or blood coagulation system.
AU2001252772A 2000-03-24 2001-03-22 Use of amines Abandoned AU2001252772A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0007239 2000-03-24
GBGB0007239.7A GB0007239D0 (en) 2000-03-24 2000-03-24 Use
PCT/NO2001/000123 WO2001072669A2 (en) 2000-03-24 2001-03-22 Therapeutic use of polyhydroxy amine derivates

Publications (1)

Publication Number Publication Date
AU2001252772A1 true AU2001252772A1 (en) 2001-10-08

Family

ID=9888396

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001252772A Abandoned AU2001252772A1 (en) 2000-03-24 2001-03-22 Use of amines

Country Status (8)

Country Link
US (1) US7060731B2 (en)
EP (1) EP1282592B1 (en)
JP (1) JP2003528836A (en)
AT (1) ATE296281T1 (en)
AU (1) AU2001252772A1 (en)
DE (1) DE60111044T2 (en)
GB (1) GB0007239D0 (en)
WO (1) WO2001072669A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060100127A1 (en) 2004-11-11 2006-05-11 Meier Ingrid K N,N-dialkylpolyhydroxyalkylamines
US8061515B2 (en) * 2010-02-19 2011-11-22 Michael Carrasquillo Compact disc storage and protective enclosure
CA2997791A1 (en) * 2015-09-30 2017-04-06 Duke University Ascorbate formulations and methods of use as contrast agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2919229A (en) * 1957-11-22 1959-12-29 Us Vitamin Corp N-methylglucamine salts of alphanaphthyl and acyl 1, 3-indandione and methods of using same
US3906109A (en) * 1972-02-09 1975-09-16 Dan Christian Roehm Blood clotting depressant therapy
JPH0678241B2 (en) * 1986-04-02 1994-10-05 エーザイ株式会社 tPA pharmaceutical composition
US5028625A (en) * 1989-06-20 1991-07-02 American Home Products Corporation Acid addition salt of ibuprofen and meglumine
IL98744A0 (en) * 1990-07-06 1992-07-15 Gen Hospital Corp Method of studying biological tissue using monocrystalline particles
JPH09511516A (en) * 1994-04-12 1997-11-18 カイロサイエンス・リミテッド Method for partitioning etodolac with glucamine derivatives
CA2192682A1 (en) * 1994-06-29 1996-01-11 Alfred Sallmann New salts of 2-¬(2,6-dichlorophenyl)amine|phenylacetoxyacetic acid with organic basic cations
AU1885999A (en) * 1998-02-17 1999-08-30 Miciopharma Chemical Aktiengesellschaft A watersoluble nimesulide adduct also for injectable use
US6093743A (en) * 1998-06-23 2000-07-25 Medinox Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor

Also Published As

Publication number Publication date
DE60111044T2 (en) 2006-05-04
US20030045586A1 (en) 2003-03-06
US7060731B2 (en) 2006-06-13
DE60111044D1 (en) 2005-06-30
GB0007239D0 (en) 2000-05-17
ATE296281T1 (en) 2005-06-15
EP1282592A2 (en) 2003-02-12
WO2001072669A3 (en) 2002-01-03
WO2001072669A2 (en) 2001-10-04
EP1282592B1 (en) 2005-05-25
JP2003528836A (en) 2003-09-30

Similar Documents

Publication Publication Date Title
HK1052708A1 (en) Glutamine-thiazolidide and-pyrrolidide and their use as depeptidylpeptidase iv inhibitors.
TR200103493T2 (en) Metalloprotease inhibitors
BR0014078A (en) Xa factor inhibitors
DE60218458D1 (en) ISOCHINOLINONE DERIVATIVES AS PARP INHIBITORS
BR9916111A (en) Phenylglycine derivatives
BR0109703A (en) Piperazine Derivatives
CA2376497A1 (en) Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging
BR9811099A (en) Urokinase inhibitors
TR200200883T2 (en) 2-substituted 1,1-biphenyl-2-carbonamides, manufacturing methods, use as drugs
DE60017878D1 (en) COMBINATION PREPARATIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ANGIOGENESIS
ATE416157T1 (en) INHIBITORS OF INTEGRIN ALPHA-V-BETA-6
AU2001266575A1 (en) Chemical compounds
BR0109542A (en) Alkylated imidazopyrine derivatives
BR0213994A (en) Heterocyclic Glycinamide Derivatives and Their Medical Uses
WO2003018059A3 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
DE60112960D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
RS49599B (en) Use of h+, k+ -atpaze inhibitors and glucocortifoids and pharmaceutical formulation
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
DE60128100D1 (en) ANALGICAL DRUG
WO2002038563A3 (en) Condensed pyrazindione derivatives as pde inhibitors
AU2001252772A1 (en) Use of amines
DK1015437T3 (en) Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
AU2002211493A1 (en) Indole derivatives as pde5-inhibitors
WO2002006280A3 (en) INHIBITORS OF FACTOR Xa
DE60121048D1 (en) PYRAZINOi1'2 ': 1,6öPYRIDOi3,4-BöINDOLDERIVATE